Trial intelligence / Profile preview

Effect of Age, Weight and Sex on Levothyroxine Pharmacokinetics

NCT03102177Phase 1Completed

Sponsor
Georgetown University
Start
May 2011
Primary completion
Nov 2013
Modality
Small Molecules
01

Overview

Phase 1, open-label, single-arm trial of levothyroxine sodium in hypothyroidism, sponsored by Georgetown University. Primary endpoints: Apparent Clearance at 120 hours, Apparent Volume of Distribution at 120 hours and 1 more. Started May 2011; status: completed.

02

Drugs

levothyroxine sodium
03

Conditions

hypothyroidism

Beyond the preview

Go deeper on NCT03102177.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03102177.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call